Q3 2025 Evolent Health Inc Earnings Call Transcript
Key Points
- Evolent Health Inc (EVH) reported Q3 revenue of $479.5 million, which was at the top of their guidance range.
- The company announced two new revenue arrangements, expected to add over $550 million in new 2026 revenue.
- Q3 adjusted EBITDA was $39 million, representing 23% growth year over year.
- Evolent Health Inc (EVH) is implementing AI efficiency improvements, which are beginning to show positive results.
- The company plans to use proceeds from the sale of its primary care business to pay down approximately $100 million of senior term loan, reducing cash interest burden by about $10 million annually.
- The 2026 adjusted EBITDA outlook is uncertain due to potential membership declines in Medicaid, exchange, and Medicare Advantage markets.
- There is a risk of significant membership declines in the exchange market, with forecasts ranging from 15% to 65%.
- The company anticipates minimal adjusted EBITDA contribution from new launches in 2026.
- Evolent Health Inc (EVH) has a net debt of $910 million, reflecting a high leverage ratio.
- The company is facing industry-wide challenges, including potential benefit rushes and increased medical utilization in the exchange book.
Welcome to the Evolent earnings conference call for the third quarter ended September 30, 2025. As a reminder, this conference call is being recorded.
Your hosts for the call today from Evolent are Seth Blackley, Chief Executive Officer; and John Johnson, Chief Financial Officer. This call will be archived and available later this evening and for the next week via the webcast on the company's website in the section titled Investor Relations.
This conference call will contain forward-looking statements under the US federal laws. These statements are subject to risks and uncertainties that could cause actual results to differ materially from historical experience or present expectations. A description of some of the risks and uncertainties can be found in the company's reports that are filed with the Securities and Exchange Commission, including cautionary statements included in our current and periodic filings.
For additional information on the company's results and outlook, please refer to our third quarter press release issued earlier today.
Finally, as a reminder,
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
Trustpilot
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
